US 11,053,282 B2
Peptoid affinity ligands
Andrew J. Murphy, Cary, NC (US); Tee Bordelon, Holly Springs, NC (US); and Michael Crapanzano, Baton Rouge, LA (US)
Assigned to MIKE-ANN, LLC, Baton Rouge, LA (US)
Appl. No. 16/83,366
Filed by MIKE-ANN, LLC, Baton Rouge, LA (US)
PCT Filed Mar. 9, 2017, PCT No. PCT/US2017/021660
§ 371(c)(1), (2) Date Sep. 7, 2018,
PCT Pub. No. WO2017/156324, PCT Pub. Date Sep. 14, 2017.
Claims priority of provisional application 62/305,831, filed on Mar. 9, 2016.
Claims priority of provisional application 62/305,835, filed on Mar. 9, 2016.
Prior Publication US 2019/0085022 A1, Mar. 21, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 7/06 (2006.01); C07K 5/083 (2006.01); B01D 15/38 (2006.01); B01J 20/26 (2006.01); C07K 1/22 (2006.01); B01J 20/289 (2006.01); B01J 20/32 (2006.01); C07K 16/00 (2006.01); C07K 5/103 (2006.01); C07K 7/02 (2006.01); C07K 5/11 (2006.01)
CPC C07K 1/22 (2013.01) [B01D 15/3809 (2013.01); B01J 20/265 (2013.01); B01J 20/289 (2013.01); B01J 20/3204 (2013.01); B01J 20/3208 (2013.01); B01J 20/3212 (2013.01); B01J 20/3219 (2013.01); B01J 20/3274 (2013.01); C07K 5/0806 (2013.01); C07K 5/1008 (2013.01); C07K 5/1019 (2013.01); C07K 7/02 (2013.01); C07K 7/06 (2013.01); C07K 16/00 (2013.01); B01J 2220/52 (2013.01)] 5 Claims
OG exemplary drawing
 
1. A peptoid affinity ligand selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
wherein the peptoid affinity ligand has a binding affinity to an immunoglobulin, immunoglobulin fragment or immunoglobulin fusion protein thereof.